Glenmark Pharmaceuticals Inc., USA is voluntarily recalling 22,656 bottles of Glenmark brand Theophylline extended-release tablets (400 mg, 100-count bottles). Theophylline (theophylline) is a prescription medication used to treat and prevent symptoms of asthma, chronic bronchitis, and emphysema. This recall was issued because recent stability testing showed the tablets failed to meet dissolution standards, meaning the medication may not release into the body as intended at the end of its shelf life.
If the medication fails to dissolve properly, patients may receive inconsistent doses, potentially leading to a lack of effectiveness in managing respiratory symptoms. No adverse events or injuries have been reported to date in connection with this issue.
You have 2 options:
Manufactured by Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa- 403513 India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.